• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.15% Nasdaq Down 0.05%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    82.71 Down 4.59(5.26%) 11:30AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:87.30
    Open:87.37
    Bid:83.27 x 100
    Ask:83.53 x 100
    1y Target Est:95.50
    Beta:0.97
    Next Earnings Date:11-May-15LGND Earnings announcement
    Day's Range:80.60 - 88.39
    52wk Range:41.99 - 90.48
    Volume:383,387
    Avg Vol (3m):398,150
    Market Cap:1.62B
    P/E (ttm):147.70
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 5.26%1.62B
    LLYUp 0.28%75.40B
    MRKUp 5.13%169.79B
    RHHBYDown 1.17%N/A

    Key Statistics

    Forward P/E (1 yr):25.48
    P/S (ttm):26.48
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.13
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.92

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback